CompletedNot Applicable

Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia

China10 participantsStarted 2019-02-27

Plain-language summary

Nowadays, multiple treatment modalities have been applied clinically to treat androgenic alopecia, such as Follicular unit transplantation(FUT), finasteride, platelet-rich plasma injection(PRP), etc. In this clinical trial, the investigators aim to analyze the effect of nanofat grafting on treating androgenic alopecia in male.

Who can participate

Age range18 Years – 50 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male patients with androgenic alopecia aging from 18 to 50. * No scars and wounds on the alopecia area. * No skin disease or serious cardiovascular disease. * Preoperative examinations remain healthy. Exclusion Criteria: * Serious chronic heart, liver, kidney, blood system disease * Allergic diseases, skin inflammation or wounds * Alopecia but not androgenic alopecia * Acute or chronic infection * Take anticoagulant drugs * Active vitiligo, psoriasis, systemic lupus erythematosus

What they're measuring

Dermatoscope

Timeframe: Baseline and at1,3,6,9,12 months after the treatment

Trial details

NCT IDNCT03506503

SponsorJinan University Guangzhou

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-02-27

View on ClinicalTrials.gov More Androgenic Alopecia trials